Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast canc...
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
CD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) remains obscure. The current study aims to assess the prognostic value of CD133 expression in early invasive BC.
Methods
CD133
mRNA was assessed in the M...
Alternative Titles
Full title
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_2157658724
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2157658724
Other Identifiers
ISSN
0167-6806
E-ISSN
1573-7217
DOI
10.1007/s10549-018-05085-9
